Parkinson's Disease Clinical Trials in Philadelphia, Pennsylvania

5 studies are recruiting for parkinson's disease in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Parkinson's Foundation PD GENEration Genetic Registry

   Development of a central repository for PD-related genomic data for future research.

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Pennsylvania, Philadelphia, Pennsylvania

   Locations

   70 in total

   Run by

   Parkinson's Foundation

   See if you can join NCT04994015 on ClinicalTrials.gov

2. A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

   This is an observational study in which data are collected and studied from Parkinson's disease patients who have movement symptoms despite taking standard Parkinson's medications. In observational studies, observations are made without any changes to the participant's healthcare or treatment plan.…

   Stage

   Not phased

   Ages

   45 to 75

   Site

   Thomas Jefferson University, Philadelphia, Pennsylvania

   Locations

   27 in total

   Run by

   Bayer

   See if you can join NCT07330258 on ClinicalTrials.gov

3. A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

   The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of prasinezumab compared with placebo in participants with early-stage Parkinson's disease (PD) on stable symptomatic monotherapy with levodopa.

   Stage

   Phase 3

   Ages

   50 to 85

   Site

   University Pennsylvania Hospital, Philadelphia, Pennsylvania

   Locations

   192 in total

   Run by

   Hoffmann-La Roche

   See if you can join NCT07174310 on ClinicalTrials.gov

4. A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

   The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics/pharmacodynamics (PK/PD) of LY3962681 in healthy volunteers and patients with Parkinson's disease. The study consists of two parts, the Single Ascending Dose (SAD) study and the Multiple Ascending Dose (MAD) stu…

   Stage

   Phase 1

   Ages

   30 to 80

   Site

   University of Pennsylvania, Dept of Neurology, Philadelphia, Pennsylvania

   Locations

   16 in total

   Run by

   Prevail Therapeutics

   See if you can join NCT06565195 on ClinicalTrials.gov

5. Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2)

   Parkinson's Disease (PD) is the second most common of the age-related neurodegenerative disorders, affecting over 1,900 adults per 100,000 over the age of 80 in the US. The prevalence of sleep dysfunction in PD is estimated at nearly 80-90% which includes sleep fragmentation, insomnia, rapid eye mo…

   Stage

   Not phased

   Ages

   18 to 80

   Site

   University of Pennsylvania Health System, Philadelphia, Pennsylvania

   Locations

   2 in total

   Run by

   University of Nebraska

   See if you can join NCT05070013 on ClinicalTrials.gov